Global regulators including members of the ICH Q9(R1) Expert Working Group will participate in discussions on the background, issues, and status of the ICH Q9 revision and provide perspectives on the current state of application of quality risk management in industry. Discussion panels and breakouts will address practical implementation of the key focus areas of the ICH Q9 Revision: Subjectivity, Product Availability, Formality, Decision-making, Digitization and New Technology/Modalities. Attendees will be able to provide their thoughts to regulators on the training needed to implement the updated ICH Q9.
Gain the knowledge and competitive edge you need to succeed in the pharmaceutical and biopharmaceutical engineering industries and join more than 18,000 pharma professionals from around the world by becoming an ISPE Member.
Online access to select ISPE Good Practice Guides that will help you learn how to practically implement best practices and principles
Member-only discounts on Guidance Documents, Conferences, and Training
Pharmaceutical Engineering® magazine
Communities of Practice access to pharma professionals in specific topics from around the world